MedTrace Logo

Iron and COVID-19 Vaccine Response

NCT04915820 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 121

Last updated 2025-09-04

No results posted yet for this study

Summary

Vaccines often underperform in Africa compared to high-income countries. Why vaccines do not work as well in Africa remains uncertain. Malnutrition likely plays a role. Our study objective is to assess whether iron deficiency anaemia in young women impairs their immune response to the COVID-19 vaccine, and whether iron treatment improves their response.

Conditions

Interventions

DIETARY_SUPPLEMENT

Ferinject

intravenous iron carboxymaltose

Sponsors & Collaborators

  • Jomo Kenyatta University of Agriculture and Technology

    lead OTHER

Principal Investigators

  • Simon Karanja, PhD · JKUAT Nairobi

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-29
Primary Completion
2021-09-09
Completion
2021-09-09

Countries

  • Kenya

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04915820 on ClinicalTrials.gov